The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development-Reference-Cited by-同舟云学术

The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development

Published:2015-04-13 Issue:7-8 Volume:9 Page:732-744
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Heikkinen Aki T.¹,Lignet Floriane²,Cutler Paul²,Parrott Neil²

Affiliation:

1. School of Pharmacy; Faculty of Health Sciences; University of Eastern Finland; Kuopio Finland

2. Pharmaceutical Sciences; Pharmaceutical Research & Early Development; Roche Innovation Center Basel; Basel Switzerland

Publisher

Wiley

Subject

Clinical Biochemistry

Reference130 articles.

1. Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development;Jones;CPT Pharmacometrics Syst. Pharmacol.,2013

2. Application of physiologically based pharmacokinetic models in chemical risk assessment;Mumtaz;J. Toxicol.,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ontogeny of CYP3A and UGT activity in preterm piglets: a translational model for drug metabolism in preterm newborns;Frontiers in Pharmacology;2023-04-13

2. A method for quantification of human transporter proteins by liquid chromatography–tandem mass spectrometry;SEPARATION SCIENCE PLUS;2023-02-17

3. Physiologically Based Models: Techniques and Applications to Drug Delivery;Drug Delivery Approaches;2021-07-27

4. Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment;Alimentary Pharmacology & Therapeutics;2021-07-04

5. Hepatic Cytochrome P450 Abundance and Activity in the Developing and Adult Göttingen Minipig: Pivotal Data for PBPK Modeling;Frontiers in Pharmacology;2021-04-15